J Neuroinflamm (2013) 10:142
More translational and clinical studies are needed to determine whether ferroptosis can be used as a treatable pathway in DKD and to define its role in the long-term benefits of SGLT2 inhibitors
independently extracted the following information from the included meta-analyses: first author, publication year, intervention type, study population, study design, number of included trials, number of participants, outcomes, effect model, effect size, heterogeneity, and publication bias
David Ricks, Eli Lillys chair and CEO, commented on the investment, stating, This new $5.3 billion investment tops the largest manufacturing investment in our companys history and, we believe, represents the single largest investment in synthetic medicine API manufacturing in US history